BGB-68612-59512
4 vaccinations
2 coded responses
47 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 802 / CO
- Registered
- 2021-02-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-04
Registered in v-safe
-
2021-02-04
Dose 1 — Moderna
-
2021-02-04
Health check-in — day 0, dose 1Feeling: Good · Site: Pain · Headache, Muscle or body achesAdult check-in
- 2021-02-05
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-09
- 2021-02-10
- 2021-02-11
- 2021-02-18
- 2021-02-25
-
2021-03-04
Dose 2 — Moderna
- 2021-03-04
-
2021-03-05
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-06
- 2021-03-07
- 2021-03-08
- 2021-03-09
- 2021-03-10
- 2021-03-11
- 2021-03-18
- 2021-03-25
- 2021-04-01
- 2021-04-08
- 2021-04-15
- 2021-06-03
-
2021-09-02
Survey response — 6 months, dose 2MedDRA: Exposure to SARS-CoV-2, Oropharyngeal pain, Paranasal sinus discomfort, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Sinus pressure and sore throat for several days after being exposed to Covid, however tested negative.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-09-02
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-09-08
-
2021-09-13
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2021-10-28
Dose 3 — Moderna
- 2021-10-28
-
2021-10-29
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Abdominal painAdult check-in
- 2021-10-30
- 2021-10-31
- 2021-11-01
- 2021-11-02
- 2021-11-03
- 2021-11-04
- 2021-11-11
- 2021-11-18
- 2021-11-25
- 2021-12-02
-
2021-12-09
Survey response — day 42, dose 3MedDRA: Lymphadenopathy — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Swollen lymph nodes in throatMedDRA releases: 2024-11 · check-in free text available
-
2021-12-09
Report sent to call center — day 42, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-12-10
-
2021-12-10
Call successfulParticipant prefers to complete VAERS report online
- 2022-01-27
- 2022-04-28
-
2022-10-06
Dose 4 — Pfizer-BioNTech
- 2022-10-28
- 2022-10-28
- 2022-11-03
- 2022-11-10
- 2022-11-17
- 2023-01-05
- 2023-04-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-04 | Moderna | |
| 2 | 2021-03-04 | Moderna | |
| 3 | 2021-10-28 | Moderna | No |
| 4 | 2022-10-06 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 successful
Free text
Release 9 — 6 months, dose 2
Symptoms: Sinus pressure and sore throat for several days after being exposed to Covid, however tested negative.
Release 10 — day 42, dose 3
Symptoms: Swollen lymph nodes in throat
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Exposure to SARS-CoV-2 | ✓ | · | ✓ |
| SD | Lymphadenopathy | · | · | ✓ |
| SD | Oropharyngeal pain | ✓ | · | ✓ |
| SD | Paranasal sinus discomfort | ✓ | · | ✓ |
| SD | SARS-CoV-2 test negative | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release